The Abl family kinases: Mechanisms of regulation and signaling

Advances in Cancer Research

Volumn 85, Issue , 2002, Pages 51-100

  Pendergast, Ann Marie ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; AMINO ACID; BCR ABL PROTEIN; CISPLATIN; F ACTIN; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN C; PROTEIN P73; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CATALYSIS; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CYTOSKELETON; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; GROWTH CONE; HUMAN; IONIZING RADIATION; MOLECULAR INTERACTION; MORPHOGENESIS; NERVE FIBER GROWTH; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 0036391801     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(02)85003-5     Document Type: Review

References (179)

1. Agami, R., Blandino, G., Oren, M., and Shaul, Y. (1999). Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature 399, 809-813.
2. Alexandropoulos, K., Cheng, G., and Baltimore, D. (1995). Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92, 3110-3114.
3. Bagrodia, S., and Cerione, R. A. (1999). PAK to the future. Trends Cell Biol. 9, 350-355.
4. Barilá, D., and Superti-Furga, G. (1998). An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18, 280-282.
5. Barilá, D., Mangano, R., Gonfloni, S., Kretzschmar, J., Moro, M., Bohmann, D., and SupertiFurga, G. (2000). A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK. EMBO J. 19, 273-281.
6. Bashaw, G., Kidd, T., Murray, D., Pawson, T., and Goodman, C. S. (2000). Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell 101, 703-715.
7. Baskaran, R., Dahmus, M. E., and Wang, J. Y. J. (1993). Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA 90, 11, 167-11, 171.
8. Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., and Wang, J. Y. (1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519.
9. Bateman, J., Shu, H., and Van Vactor, D. (2000). The guanine nucleotide exchange factor trio mediates axonal development in the Drosophila embryo. Neuron 26, 93-106.
10. Baum, B., and Perrimon, N. (2001). Spatial control of the actin cytoskeleton in Drosophila epithelial cells. Nat. Cell Biol. 3, 883-890.
11. Ben-Neriah, Y., Bernards, A., Paskind, M., Daley, G. Q., and Baltimore, D. (1986). Alternative 5′ exons in c-abl mRNA. Cell 44, 577-586.
12. Bennett, R., and Hoffmann, F. M. (1992). Increased levels of the Drosophila Abelson tyrosine kinase in nerves and muscles: Subcellular localization and mutant phenotypes imply a role in cell-cell interactions. Development 116, 953-966.
13. Bhatia, R., and Verfaillie, C. (2001). Abnormalities in hematopoietic progenitor adhesion. In "Chronic Myeloid Leukaemia: Biology and Treatment." Martin Dunitz Ltd., London, pp. 40-54.
14. Brasher, B. B., and Van Etten, R. A. (2000). C-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distrinct regulatory tyrosines. J. Biol. Chem. 275, 35, 631-35, 637.
15. Brasher, B. B., Roumiantsev, S., and Van Etten, R. A. (2001). Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain. Oncogene 20, 7744-7752.
16. Cao, C., Ren, X., Kharbanda, S., Koleske, A., Prasad, K., and Kufe, D. (2001). The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. J. Biol. Chem. 276, 11, 465-11, 468.
17. Chen, G., Shyng-Shiou, F. Y., Liu, W., Xu, Y., Trujillo, K., Song, B., Cong, F., Goff, S. P., Wu, Y., Arlinghaus, R., Baltimore, D., Gasser, P. J., Park, M. S., Sung, P., and Lee, E. Y.-H. P. (1999). Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274, 12, 748-12, 752.
18. Cicchetti, P., Mayer, B. J., Thiel, G., and Baltimore, D. (1992). Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257, 803-806.
19. Cong, F., and Goff, S. P. (1999). C-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation. Proc. Natl. Acad. Sci. USA 96, 13,819-13,824.
20. Cong, F., Spencer, S., Cote, J.-F., Wu, Y., Tremblay, M. L., Lasky, L. A., and Goff, S. (2000). Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. Mol. Cell 6, 1413-1423.
21. Courtney, K. D., Grove, M., Vandongen, H., Vandongen, A., LaMantia, A.-S., and Pendergast, A. M. (2000). Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Mol. Cell. Neurosci. 16, 244-257.
22. Dai, Z., and Pendergast, A. M. (1995). Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9, 2569-2582.
23. Dai, Z., Quackenbush, R. C., Courtney, K. D., Grove, M., Cortez, D., Reuther, G. W., and Pendergast, A. M. (1998). Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes Dev. 12, 1415-1424.
24. Daniel, R., Cai, Y., Wong, P. M. C., and Chung, S.-W. (1995). Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene 10, 1607-1614.
25. Daniel, R., Wong, P., and Chung, S. (1996). Isoform-specific functions of c-abl: Type I is necessary for differentiation, and type IV is inhibitory to apoptosis. Cell Growth Differ. 7, 1141-1148.
26. Daniels, R. H., Hall, P. S., and Bokoch, G. M. (1998). Membrane targeting of p21-activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells. EMBO J. 17, 754-764.
27. David-Cordonnier, M. H., Hamdane, M., Bailly, C., and D'Halluin, J.-C. (1998). The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. Biochemistry 37, 6065-6076.
28. Dorey, K., Barila, D., Gavin, A.-C., Nebreda, A. R., and Superti-Furga, G. (1999). Regulation of human c-Abl tyrosine kinase activity in Xenopus oocytes and acceleration of progesterone-induced G2/M transition by oncogenic forms. Biol. Chem. 380, 223-230.
29. Dorey, K., Engen, J. R., Kretzschmar, J., Wilm, M., Neubauer, G., Schindler, T., and Superti-Furga, G. (2001). Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase. Oncogene 20, 8075-8084.
30. Dorsch, M., and Goff, S. P. (1996). Increased sensitivity to apoptotic stimuli in C-abl-deficient progenitor B-cell lines. Proc. Natl. Acad. Sci. USA 93, 13, 131-13, 136.
31. Echarri, A., and Pendergast, A. M. (2001). Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr. Biol. 11, 1759-1765.
32. Elkins, T., Zinn, K., McAllister, L., and Hoffmann, F. M. (1990). Genetic analysis of a Drosophila neural cell adhesion molecule: Interaction of fasciclin I and Abelson tyrosine kinase mutations. Cell 60, 565-575.
33. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B., and Tedder, T. F. (1995). Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3, 39-50.
34. Fan, P. D., and Goff, S. P. (2000). Abl interactor 1 binds to Sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases. Mol. Cell. Biol. 20, 7591-7601.
35. Franz, W., Berger, P., and Wang, J. Y. J. (1989). Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8, 137-147.
36. Frasca, F., Vigneri, P., Vella, V., Vigneri, R., and Wang, J. Y. T. (2001). Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to hepatocyte growth factor. Oncogene 20, 3845-3856.
37. Fujimoto, M., Fujimoto, Y., Poe, J. C., Jansen, P. J., Lowell, C. A., DeFranco, A. L., and Tedder, T. F. (2000). CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity 13, 47-57.
38. Gertler, F. B., Bennett, R. L., Clark, M. J., and Hoffmann, F. M. (1989). Drosophila abl tyrosine kinase in embryonic CNS axons: A role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58, 103-113.
39. Gertler, F. B., Doctor, J. S., and Hoffmann, F. M. (1990). Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog. Science 248, 857-860.
40. Gertler, F. B., Hill, K. K., Clark, M. J., and Hoffman, F. M. (1993). Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero a regulator of axonal outgrowth, and disabled a novel tyrosine kinase substrate. Genes Dev. 7, 441-453.
41. Gertler, F. B., Comer, A. R., Juang, J. L., Ahern, S. M., Clark, M. J., Liebl, E. C., and Hoffmann, F. M. (1995). Enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties. Genes Dev. 9, 521-533.
42. Gishizky, M. L. (2001). Target-directed therapies. In "Chronic Myeloid Leukaemia: Biology and Treatment." Martin Dunitz Ltd., London, pp. 485-494.
43. Glover, R. T., Angiolieri, M. A., Kelly, S., Monaghan, D. T., Wang, J. Y., Smithgall, T. E., and Buller, A. L. (2000). Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase. J. Biol. Chem. 275, 12, 725-12, 729.
44. Goddard, J. M., Weiland, J. J., and Capecchi, M. R. (1986). Isolation and characterization of Caenorhabditis elegans DNA sequences homologous to the v-abl oncogene. Proc. Natl. Acad. Sci. USA 83, 2172-2176.
45. Goff, S., Gilboa, E., Witte, O., and Baltimore, D. (1980). Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA. Cell 22, 777-785.
46. Goga, A., McLaughlin, J., Pendergast, A. M., Parmar, K., Muller, A., Rosenberg, N., and Witte, O. N. (1993). Oncogenic activation of cABL by mutation within its last exon. Mol. Cell. Biol. 13, 4967-4975.
47. Goga, A., Liu, X., Hambuch, T. M., Senechal, K., Major, E., Berk, A. J., Witte, O. N., and Sawyers, C. L. (1995). p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11, 791-799.
48. Gong, J., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, Jr., W. G., Levrero, M., and Wang, J. Y. J. (1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399, 806-809.
49. Grevengoed, E. E., Loureiro, J. J., Jesse, T. L., and Peifer, M. (2001). Abelson kinase regulates epithelial morphogenesis in Drosophila. J. Cell Biol. 155, 1185-1197.
50. Groffen, J., Stephenson, J. R., Heisterkamp, N., de Klein, A., Bartram, C. R., and Grosveld, G. (1984). Philadelphia chromosomal breakpoints are clustered within a limited region, Bcr, on chromosome 22. Cell 36, 93-99.
51. Haaf, T., Golub, E. I., Reddy, G., Radding, C. M., and Ward, D. C. (1995). Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc. Natl. Acad. Sci. USA 92, 2298-2302.
52. Hardin, J. D., Boast, S., Schwartzberg, P. L., Lee, G., Alt, F. W., Stall, A. M., and Goff, S. P. (1996). Abnormal peripheral lymphocyte function in c-abl mutant mice. Cell. Immunol. 172, 100-107.
53. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265, 2896-2902.
54. Heisterkamp, J., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., and Grosveld, G. (1983). Localization of the c-abl oncogene adjacent to a translocation point in chronic myelocytic leukemia. Nature 306, 329-242.
55. Henderson, J. T., Georgiou, J., Jia, Z., Robertson, J., Elowe, S., Roder, J. C., and Pawson, T. (2001). The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 32, 1041-1056.
56. Henkemeyer, M. J., Gertler, F. B., Goodman, W., and Hoffmann, F. M. (1987). The Drosophila Abelson proto-oncogene homolog: Identification of mutant alleles that have pleiotropic effects late in development. Cell 51, 821-828.
57. Henkemeyer, M. J., Bennett, R. L., Gertler, F. B., and Hoffmann, F. M. (1988). DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster Abelson protooncogene homolog. Mol. Cell. Biol. 8, 843-853.
58. Herzog, K. H., Chong, M. J., Kapsetaki, M., Morgan, J. I., and McKinnon, P. J. (1998). Requirement for Arm in ionizing radiation-induced cell death in the developing central nervous system. Science 280, 1089-1091.
59. Higgs, H. N., and Pollard, T. D. (2001). Regulation of actin filament network formation through ARP2/3 complex: Activation by a diverse array of proteins. Annu. Rev. Biochem. 70, 649-676.
60. Hing, H., Xiao, J., Harden, N., Lim, L., and Zipursky, S. L. (1999). Pak functions downstream of dock to regulate photoreceptor axon guidance in Drosophila. Cell 97, 853-863.
61. Hoffmam F. M., Fresco, L. D., Hoffman-Falk, H., and Shilo, B.-Z. (1983). Nucleotide sequences of the Drosohpila src and abl homologs: Conservation and variability in the src family oncogenes. Cell 35, 393-401.
62. Homayouni, R., and Curran, T. (2000). Cortical development: Cdk5 gets into sticky situations. Curr. Biol. 10, R331-R334.
63. Hubbard, S. R. (1999). Src autoinhibition: Let us count the ways. Nat. Struct. Biol. 6, 711-714.
64. Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W. A. (1994). Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
65. Ikeguchi, A., Yang, H.-Y., Gao, G., and Goff, S. P. (2001). Inhibition of v-Abl transformation in 3T3 cells overexpressing different forms of the Abelson interactor protein Abi-1. Oncogene 20, 4926-4934.
66. Ito, Y., Pandey, P., Mishra, N., Kumar, S., Narula, N., Kharbanda, S., Saxena, S., and Kufe, D. (2001). Targeting of the c-Abl tyrosine kinase to mitochondria in endoplasmic reticulum stress-induced apoptosis. Mol. Cell. Biol. 21, 6233-6242.
67. Jackson, P., and Baltimore, D. (1989). N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8, 449-456.
68. Jost, C. A., Marin, M. C., and Kaelin, W. G., Jr. (1997). p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191-194.
69. Juang, J.-L., and Hoffmann, F. M. (1999). Drosophila Abelson interacting protein (dAbi) is a positive regulator of Abelson tyrosine kinase activity. Oncogene 18, 5138-5147.
70. Kadlec, L., and Pendergast, A. M. (1997). The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation. Proc. Natl. Acad. Sci. USA 94, 12, 390-12, 395.
71. Kain, K. H., and Klemke, R. L. (2001). Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. J. Biol. Chem. 276, 16, 185-16, 192.
72. Kharbanda, S., Ren, R., Pandey, P., Shafman, T., Feller, S., Weichselbaum, R., and Kufe, D. (1995a). Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376, 785-788.
73. Kharbanda, S., Pandey, P., Ren, R., Mayer, B., Zon, L., and Kufe, D. (1995b). C-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-β-D-arabinofuranosylcytosine. J. Biol. Chem. 270, 30, 278-30, 281.
74. Kharbanda, S., Pandey, P., Jin, S., Inoue, S., Bharti, A., Yuan, Z. M., Weichselbaum, R., Weaver, D., and Kufe, D. (1997). Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature 386, 732-735.
75. Kidd, T., Brose, K., Mitchell, K. J., Fetter, R. D., Tessier-Lavigne, M., Goodman, C. S., and Tear, G. (1998). Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell 92, 202-215.
76. Kidd, T., Bland, K. S., and Goodman, C. S. (1999). Slit is the midline repellent for the Robo receptor in Drosophila. Cell 96, 785-794.
77. Kipreos, E. T., and Wang, J. Y. J. (1992). Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256, 382-385.
78. Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., and Cheresh, D. A. (1998). CAS/Crk coupling serves as a molecular switch for induction of cell migration. J. Cell Biol. 140, 961-972.
79. Knebel, A., Rahmsdorf, H. J., Ullrich, A., and Herrlich, P. (1996). Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15, 5314-5325.
80. Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., and Baltimore, D. (1998). Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21, 1259-1272.
81. 2. Proc. Natl. Acad. Sci. USA 94, 11, 233-11, 237.
82. Konopka, J. B., Watanabe, S. M., and Witte, O. N. (1984). An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37, 1035-1042.
83. Konopka, J. B., and Witte, O. N. (1985). Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell. Biol. 5, 3116-3123.
84. Kruh, G. D., Perego, R., Miki, T., and Aaronson, S. A. (1990). The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl. Acad. Sci USA 87, 5802-5806.
85. Lanier, L. M., and Gertler, F. B. (2000). From Abl to actin: Abl tyrosine kinase and associated proteins in growth cone motility. Curr. Opin. Neurobiol. 10, 80-87.
86. Lavin, M., and Shiloh, Y. (1997). The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15, 177-202.
87. Lee, M., Kwon, T. T., Li, M., Peng, J., Friedlander, R. M., and Tsai, L.-H. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
88. Lewis, J. M., Baskaran, R., Taagepera, S., Schwartz, M., and Wang, J. (1996). Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. USA 93, 15,174-15,179.
89. Lewis, J. M., and Schwartz, M. A. (1998). Integrins regulate the association and phosphorylation of paxillin by c-Abl. J. Biol. Chem. 273, 14, 225-14, 230.
90. Liebl, E. C., Forsthoefel, D. J., Franco, L. S., Sample, S. H., Hess, J. E., Cowger, J. A., Chandler, M. P., Shupert, A. M., and Seeger, M. A. (2000). Dosage-sensitive, reciprocal genetic interactions between the Abl tyrosine kinase and the putative GEF trio reveal trio's role in axon pathfinding. Neuron 26, 107-118.
91. Liu, Z., Baskaran, R., Lea-Chou, E., Wood, L., Chen, Y., Karin, M., and Wang, J. Y. J. (1996). Three distinct signaling responses by murine fibroblasts to genotoxic stress. Nature 384, 273-276.
92. Loureiro, J., and Peifer, M. (1998). Roles of Armadillo, a Drosophila catenin, during central nervous system development. Curr. Biol. 8, 622-632.
93. Mayer, B., and Baltimore, D. (1994). Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14, 2883-2894.
94. McWhirter, J. R., and Wang, J. Y. J. (1991). Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol. Cell. Biol. 11, 1553-1565.
95. McWhirter, J. R., and Wang, J. Y. J. (1993). An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12, 1533-1546.
96. McWhirter, J. R., Galasso, D. L., and Wang, J. Y. J. (1993). A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell. Biol. 13, 7587-7595.
97. Melo, J. V. (1996). The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88, 2375-2384.
98. Miao, Y. J., and Wang, J. Y. J. (1996). Binding of A/T-rich DNA by three high mobility group-like domains in c-Abl tyrosine kinase. J. Biol. Chem. 271, 22, 823-22, 830.
99. Miyoshi-Akiyama, T., Aleman, L. M., Smith, J. M., Adler, C. E., and Mayer, B. J. (2001). Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene 20, 4058-4069.
100. Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., and Witte, O. N. (1991). BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11, 1785-1792.
101. Muller, R., Slamon, D. J., Tremblay, J. M., Cline, M. J., and Verma, I. M. (1982). Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature 299, 640-644.
102. Newsome, T. P., Schmidt, S., Dietzl, G., Keleman, K., Asling, B., Debant, A., and Dickson, B. J. (2000). Trio combines with Dock to regulate Pak activity during photoreceptor axon pathfinding in Drosophila. Cell 101, 283-294.
103. Nikolic, M., Dudek, H., Kwon, Y., Ramos, Y., and Tsai, L.-H. (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825.
104. Nikolic, M., Chou, M. M., Lu, W., Mayer, B. J., and Tsai, L.-H. (1998). The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395, 194-198.
105. O'Dwyer, M. E., Mauro, M. J., and Druker, B. J. (2001). ST571 as a therapeutic agent. In "Chronic Myeloid Leukaemia: Biology and Treatment." Martin Dunitz Ltd., London, pp. 501-505.
106. Ohshima, T., Ogawa, M., Veeranna, Hirasawa, M., Longenecker, G., Ishiguro, K., Pant, H. C., Brady, R. O., Kulkarni, A. B., and Mikoshiba, K. (2001). Synergistic contributions of cyclin-dependent kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain. Proc. Natl. Acad. Sci. USA 98, 2764-2769.
107. O'Neill, A. J., Cotter, T. G., Russell, J. M., and Gaffney, E. F. (1997). Abl expression in human fetal and adult tissues, tumours, and tumour microvessels. J. Pathol. 183, 325-329.
108. Pandey, P., Raingeaud, J., Kaneki, M., Weichselbaum, R., Davis, R. J., Kufe, D., and Kharbanda, S. (1996). Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms. J. Biol. Chem. 271, 23,775-23, 779.
109. Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L.-H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
110. Pendergast, A. M. (2001). BCR/ABL protein domain function and signaling. In "Chronic Myeloid Leukaemia: Biology and Treatment." Martin Dunitz Ltd., London, pp. 19-39.
111. Pendergast, A. M., Muller, A. J., Havlik, M. H., Clark, R., McCormick, F., and Witte, O. N. (1991). Evidence for regulation of the cABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88, 5927-5931.
112. Perego, R., Ron, D., and Kruh, G. D. (1991). Arg encodes a widely expressed 145-kDa protein-tyrosine kinase. Oncogene 6, 1899-1902.
113. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., and Pendergast, A. M. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13, 2400-2411.
114. Pluk, H., Dorey, K., and Superti-Furga, G. (2002). Autoinhibition of c-Abl. Cell 108, 247-259.
115. Rashid, T., Banerjee, M., and Nikolic, M. (2001). Phosphorylation of Pakl by the p35/Cdk5 kinase affects neuronal morphology. J. Biol. Chem. 276, 49, 043-49, 052.
116. Ren, R., Mayer, B., Cicchetti, P., and Baltimore, D. (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161.
117. Ren, R., Ye, Z., and Baltimore, D. (1994). Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8, 783-795.
118. Renshaw, M. W., Capozza, M. A., and Wang, J. Y. J. (1988). Differential expression of type-specific c-abl mRNAs in mouse tissues and cell lines. Mol. Cell. Biol. 8, 4547-4551.
119. Renshaw, M. W., Lewis, J. M., and Schwartz, M. A. (2000). The c-Abl tyrosine kinase contributes to the transient activation of MAP kinase in cells plated on fibronectin. Oncogene 19, 3216-3219.
120. Resh, M. D. (1994). Myristylation and palmitylation of Src family members: The fats of the matter. Cell 76, 411-413.
121. Rice, D. S., and Curran, T. (1999). Mutant mice with scrambled brains: Understanding the signaling pathways that control cell positioning in the CNS. Genes Dev. 13, 2758-2773.
122. Rickles, R. J., Botfield, M. C., Weng, Z., Taylor, J. A., Green, O. M., Brugge, J. S., and Zoller, M. J. (1994). Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J. 13, 5598-5604.
123. Roig, J., Tuazon, P. T., Zipfel, P. A., Pendergast, A. M., and Traugh, J. A. (2000). Functional interaction between c-Abl and the p21-activated protein kinase γ-PAK. Proc. Natl. Acad. Sci. USA 97, 14, 346-14, 351.
124. Rosti, V., Bergamaschi, G., Lucotti, C., Danova, M., Carlo-Stella, C., Locatelli, F., Tonon, L., Mazzini, G., and Cazzola, M. (1995). Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. Blood 86, 3387-3393.
125. Salgia, R., Brunkhorst, B., Pisick, E., Li, J.-L., Lo, S. H., Chen, L. B., and Griffin, J. D. (1995). Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210 BCR/ABL. Oncogene 11, 1149-1155.
126. Salgia, R., Li, J.-L., Ewaniuk, D. S., Pear, W., Pisick, E., Burky, S. A., Ernst, T., Sattler, M., Chen, L. B., and Griffin, J. D. (1997). BCR/ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Invest. 100, 46-57.
127. Sawyers, C. L., McLauglin, J., Goga, A., Havlik, M., and Witte, O. (1994). The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77, 121-131.
128. Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., and Kuriyan, J. (2000). Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289, 1938-1942.
129. Schtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., and Canaani, E. (1986). Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47, 277-284.
130. Schwartzberg, P. L., Stall, A. M., Hardin, J. D., Bowdish, K. S., Humaran, T., Boast, S., Harbison, M. L., Robertson, E. J., and Goff, S. P. (1991). Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65, 1165-1175.
131. Scita, G., Nordstrom, J., Carbone, R., Tenca, P., Giardina, G., Gutkind, S., Bjarnegard, M., Betsholtz, C., and Di Fiore, P. P. (1999). EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401, 290-293.
132. Shafman, T., Khanna, K. K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., Egerton, M., Shiloh, Y., Kharbanda, S., Kufe, D., and Lavin, M. F. (1997). Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523.
133. Shi, Y., Alin, K., and Goff, S. (1995). Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev. 9, 2583-2597.
134. Shishido, T., Akagi, T., Chalmers, A., Maeda, M., Terada, T., Georgescu, M.-M., and Hanafusa, H. (2001). Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 6, 431-440.
135. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997). Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
136. Slupianek, A., Schmutte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M., Pierce, A., Fishel, R., and Skorski, T. (2001). BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol. Cell 8, 795-806.
137. Smith, J. M., Katz, S., and Mayer, B. J. (1999). Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck. J. Biol. Chem. 274, 27, 956-27, 962.
138. Songyang, Z., Shoelson, S., Chaudhuri, M., Gish, G., Pawson, T., Haser, W., King, F., Roberts, T., Ratnofsky, S., Lechleider, R., et al. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778.
139. Songyang, Z., Carraway III, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., and Cantley, L. C. (1995). Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373, 536-539.
140. Stradal, T., Courtney, K. D., Rottner, K., Hahne, P., Small, J. V., and Pendergast, A. M. (2001). The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Curr. Biol. 11, 891-895.
141. Sun, X., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., Kharbanda, S., and Kufe, D. (2000a). Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen species. J. Biol. Chem. 275, 17, 237-17, 240.
142. Sun, X., Wu, F., Datta, R., Kharbanda, S., and Kufe, D. (2000b). Interaction between protein kinase C δ and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 275, 7470-7473.
143. Sun, J., Zhao, J., Schwartz, M. A., Wang, J. Y., Wiedmer, T., and Sims, P. J. (2001). C-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1. J. Biol. Chem. 276, 28, 984-28, 990.
144. Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L., McElroy, A. K., Wang, J. Y. J., and Hope, T. J. (1998). Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc. Natl. Acad. Sci. USA 95, 7457-7462.
145. Takao, N., Mori, R., Kato, H., Shinohara, A., and Yamamoto, K. (2000). C-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance. J. Biol. Chem. 275, 725-728.
146. Tessier-Lavigne, M., and Goodman, C. S. (1996). The molecular biology of axon guidance. Science 274, 1123-1133.
147. Trommsdorff, M., Borg, J. P., Margolis, B., and Herz, J. (1998). Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33, 556-33, 560.
148. Tybulewicz, V., Crawford, C., Jackson, P., Bronson, R., and Mulligan, R. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163.
149. Van Etten, R. A. (1999). Cycling, stressed out and nervous: Cellular functions of c-Abl. Trends Cell Biol. 9, 179-186.
150. Van Etten,R. A. (2001). Animal models of Philadelphia-positive leukemia. In "Chronic Myeloid Leukaemia: Biology and Treatment." Martin Dunitz Ltd., London, pp. 101-131.
151. Van Etten, R. A., Jackson, P., and Baltimore, D. (1989). The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58, 669-678.
152. Van Etten, R. A., Jackson, P. K., Baltimore, D., Sanders, M. C., Matsudaira, P. T., and Janmey, P. A. (1994). The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124, 325-340.
153. Van Etten, R. A., Debnath, J., Zhou, H., and Casasnovas, J. M. (1995). Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10, 1977-1988.
154. Vasioukhin, V., Bauer, C., Yin, M., and Fuchs, E. (2000). Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 100, 209-219.
155. Walkenhorst, J., Goga, A., Witte, O. N., and Superti-Furga, G. (1996). Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe. Oncogene 12, 1513-1520.
156. Wang, B., and Kruh, G. (1996). Subcellular localization of the Arg protein tyrosine kinase. Oncogene 13, 193-197.
157. Wang, J. Y. J., Ledley, F., Goff, S., Lee, R., Groner, Y., and Baltimore, D. (1984). The mouse c-abl locus: Molecular cloning and characterization. Cell 36, 349-356.
158. Wang, B., Mysliwiec, T., Krainc, D., Jensen, R. A., Sonoda, G., Testa, J. R., Golemis, E. A., and Kruh, G. D. (1996). Identification of ArgBP1, an Arg protein tyrosine kinase binding protein that is the human homologue of a CNS-specific Xenopus gene. Oncogene 12, 1921-1929.
159. Wang, Y., Miller, A. L., Moosseker, M. S., and Koleske, A. J. (2001). The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin. Proc. Natl. Acad. Sci. USA 98, 14, 865-14, 870.
160. Welch, P. J., and Wang, J. Y. J. (1993). A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75, 779-790.
161. Welch, P. J., and Wang, J. Y. J. (1995). Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell. Biol. 15, 5542-5551.
162. Wen, S., Jackson, P., and Van Etten, R. (1996). The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15, 1583-1595.
163. Wen, S.-T., and Van Etten, R. A. (1997). The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11, 2456-2467.
164. Westphal, R. S., Soderling, S. H., Alto, N. M., Langeberg, L. K., and Scott, J. D. (2000). Scar/WAVE-1, a Wiskott-Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold. EMBO J. 19, 4589-4600.
165. Wetzler, M., Talpaz, M., Van Etten, R., Hirsh-Ginsberg, C., Beran, M., and Kurzrock, R. (1993). Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest. 92, 1925-1939.
166. Wills, Z., Marr, L., Zinn, K., Goodman, C. S., and Vactor, D. V. (1999a). Profilin and the Abl tyrosine kinase are required for motor axon outgrowth in the Drosophila embryo. Neuron 22, 291-299.
167. Wills, Z., Bateman, J., Korey, C. A., Comer, A., and Van Vactor, D. (1999b). The tyrosine kinase Abl and its substrate enabled collaborate with the receptor phosphatase Dlar to control motor axon guidance. Neuron 22, 301-312.
168. Woodring, P. J., Hunter, T., and Wang, J. Y. J. (2001). Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J. Biol. Chem. 276, 27, 104-27, 110.
169. Xu, W., Harrison, S. C., and Eck, M. J. (1997). Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.
170. Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999). Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3, 629-638.
171. Yu, H.-H., Zisch, A. H., Dodelet, V. C., and Pasquale, E. B. (2001). Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. Oncogene 20, 3995-4006.
172. Yuan, Z. M., Huang, Y., Whang, Y., Sawyers, C., Weichselbaum, R., Kharbanda, S., and Kufe, D. (1996). Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382, 272-274.
173. Yuan, Z. M., Huang, Y., Ishiko, T., Kharbanda, S., Weichselbaum, R., and Kufe, D. (1997). Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94, 1437-1440.
174. Yuan, Z. M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Kharbanda, S., Wang, R., Sung, P., Shinohara, A., Weichselbaum, R., and Kufe, D. (1998). Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273, 3799-3802.
175. Yuan, Z. M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y. Y., Lu, H., Kharbanda, S., Weichselbaum, R., and Kufe, D. (1999). p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399, 814-817.
176. Zambrano, N., Bruni, P., Minopoli, G., Mosca, R., Molino, D., Russo, Cl., Schettini, G., Sudol, M., and Russo, T. (2001). The β-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene. J. Biol. Chem. 276, 19, 787-19, 792.
177. Zhu, J., and Shore, S. K. (1996). c-Abl tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein. Mol. Cell. Biol. 16, 7054-7062.
178. Zipfel, P. A., Grove, M., Blackburn, K., Fujimoto, M., Tedder, T. F., and Pendergast, A. M. (2000). The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. J. Immunol. 165, 6872-6879.
179. Zukerberg, L. R., Patrick, G. N., Nikolic, M., Humbert, S., Wu, C. L., Lanier, L. M., Gertler, F. B., Vidal, M., Van Etten, R. A., and Tsai, L. H. (2000). Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26, 633-646.